StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Deutsche Bank Raises Pfizer (PFE) PT Prior To tafamidis Data
August 21, 2018 6:30 AM
Deutsche Bank analyst, Gregg Gilbert, reiterated his Buy rating on shares of Pfizer (NYSE: PFE) and raised his price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
Pfizer (PFE), Astellas Pharma Inc. Reports Amendments to Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide
August 22, 2018 5:01 PM